FIELD: medicine.
SUBSTANCE: means relates to medicine and is intended for prevention and treatment of benign prostatic hyperplasia. For benign prostatic hyperplasia prevention and treatment, 4-hydroxymethyl-2,6-diisobornylphenol dosed as 10 mg/kg of body weight is used.
EFFECT: increased efficiency of benign prostatic hyperplasia prevention and treatment.
9 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIPROLIFERATIVE AGENT | 2011 |
|
RU2519727C2 |
| ANTIPROLIFERATIVE AGENT | 2012 |
|
RU2482857C1 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
| LOW-TOXIC 1,3,4-OXADIAZOLE DERIVATIVES OF DEOXYCHOLIC ACID WITH PROSTATE-PROTECTIVE AND ANTI-INFLAMMATORY ACTION | 2023 |
|
RU2819604C1 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
| MEDICATION FOR TREATING GENITOURINARY SYSTEM DISEASES AND METHOD OF TREATING GENITOURINARY SYSTEM DISEASES | 2011 |
|
RU2565400C2 |
| 1,2,4-OXADIAZOLE DERIVATIVES OF DESOXYCHOLIC ACID, EXHIBITING PROSTATE-PROTECTIVE EFFECT, HYPOCHOLESTEROLEMIC AND ANTI-INFLAMMATORY ACTIVITY | 2020 |
|
RU2750488C1 |
| METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
| MEDICATION (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CHEMOPROPHYLAXIS OF PROSTATE PRE-CANCER AND CANCER | 2012 |
|
RU2571818C2 |
| PDE INHIBITORS AND THEIR COMBINATIONS FOR TREATMENT OF UROLOGIC DISORDERS | 2006 |
|
RU2435588C2 |
